Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
A Phase 1, First-in-human, Dose Escalation and Expansion, Multicenter Study of XMT-1660 in Participants With Solid Tumors
A Study of XMT-1660 in Solid Tumors
Triple Negative Breast CancerBreast CancerEndometrial Cancer+4 more
Mersana TherapeuticsNCT05377996
Phase 2
A Phase 2 Study of Senaparib in Combination With Temozolomide in ARID1A Mutation Associated Ovarian Cancer
This is a phase 2 study to test the effectiveness (anti-tumor activity) of the combination of the study drugs, Senaparib and Temozolomide, in patients with cle…
Ovary CancerFallopian Tube CancerPrimary Peritoneal Cavity Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsNCT06617923